APYX MEDICAL CORPORATION ANNOUNCES APPROVAL FROM FDA TO BEGIN PHASE II OF U.S. IDE STUDYBy ApyxMedical|2025-12-12T19:34:58+00:00November 23, 2020|
APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2020 FINANCIAL RESULTSBy ApyxMedical|2025-12-12T19:35:21+00:00November 9, 2020|
APYX MEDICAL CORPORATION ANNOUNCES UPDATES ON U.S. IDE CLINICAL STUDIESBy ApyxMedical|2025-12-12T19:35:52+00:00November 9, 2020|
